Hi mate,
Good post. I agree the CR was hot handled as smooth as we all may have liked. You are also correct we are probably not priced where we should be.
But when you look at the holistic picture this company is placed at such an advantage over anyone in this sector. Again to get to phase 2 with a revolutionary product takes many many many years. BOT is also diversified in that regard.
You just need to take one look at BIT the last few days to see what an ounce of positivity can do. Done a few bags in quick time!
I have no doubt this company is onto something here and I’m happy to see it out. Not many opportunities in specs at all and the risk of no cash is taken away.
A no brainer for mine for those that like some risk.
All the best.
Ann: Ethics Approval for BTX 1308 Psoriasis Patient Study Secured, page-33
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.005(1.41%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.0¢ | 35.0¢ | $230.9K | 653.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 89180 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 138744 | 8 |
View Market Depth
| Last trade - 10.50am 27/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
